Development of a Scalable Synthesis of Gastrazole (JB95008): A Potent CCK2 Receptor Antagonist
摘要:
A practical and scalable synthesis was developed that was used to prepare multikilogram batches of gastrazole, a selective cholecystokinin-2 receptor antagonist. In addition, evidence was found to indicate an amide bond-forming reaction proceeded via the isoimide of a benzimidazoleamide acid derivative.
Organic Process Research and Development. 2005, 9, 499-507
作者:
DOI:——
日期:——
Development of a Scalable Synthesis of Gastrazole (JB95008): A Potent CC<i>K</i><sub>2</sub> Receptor Antagonist
作者:Dominic Ormerod、Bert Willemsens、Rit Mermans、Jaak Langens、Guy Winderickx、S. Barret Kalindjian、Ildiko M. Buck、Iain M. McDonald
DOI:10.1021/op0500638
日期:2005.7.1
A practical and scalable synthesis was developed that was used to prepare multikilogram batches of gastrazole, a selective cholecystokinin-2 receptor antagonist. In addition, evidence was found to indicate an amide bond-forming reaction proceeded via the isoimide of a benzimidazoleamide acid derivative.
J. Med. Chem. 1996, 39, 1806-1815
作者:
DOI:——
日期:——
Gastrin and CCK antagonists
申请人:James Black Foundation Limited
公开号:US05912260A1
公开(公告)日:1999-06-15
Described herein are compounds of formula (I) or a pharmaceutically acceptable salt thereof, ##STR1## wherein L is N or C, one of X and Y is --NH--CH.sub.2 --R.sup.2 and the other is the substituent of formula (II). The compounds are potent gastrin and/or CCK antagonists.